Overview

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if insulin, when administered as a "nasal spray" into the nasal passages, improves memory in adults with mild cognitive impairment (MCI) or Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute on Aging (NIA)
Treatments:
Insulin
Insulin, Globin Zinc